Streptococcus pneumoniae is a diverse species causing invasive as well as localized infections that result in massive global morbidity and mortality. Strains vary markedly in pathogenic potential, but the molecular basis is obscured by the diversity and plasticity of the pneumococcal genome. We have previously reported that S. pneumoniae serotype 3 isolates belonging to the same multilocus sequence type (MLST) differed markedly in in vitro and in vivo phenotypes, in accordance with the clinical site of isolation, suggesting stable niche adaptation within a clonal lineage. In the present study, we have extended our analysis to serotype 14 clinical isolates from cases of sepsis or otitis media that belong to the same MLST (ST15). In a murine intranasal challenge model, five ST15 isolates (three from blood and two from ears) colonized the nasopharynx to similar extents. However, blood and ear isolates exhibited significant differences in bacterial loads in other host niches (lungs, ear, and brain) at both 24 and 72 h postchallenge. In spite of these differences, blood and ear isolates were present in the lungs at similar levels at 6 h postchallenge, suggesting that early immune responses may underpin the distinct virulence phenotypes. Transcriptional analysis of lung tissue from mice infected for 6 h with blood isolates versus ear isolates revealed 8 differentially expressed genes. Two of these were exclusively expressed in response to infection with the ear isolate. These results suggest a link between the differential capacities to elicit early innate immune responses and the distinct virulence phenotypes of clonally related S. pneumoniae strains.
Streptococcus pneumoniae (pneumococcus) is one of the foremost bacterial pathogens in terms of global morbidity and mortality. Its disease spectrum includes life-threatening infections such as pneumonia, meningitis, and bacteremia as well as lessserious but highly prevalent infections, including otitis media (OM) and sinusitis. Young children and the elderly are at highest risk, with global estimates of pneumococcal deaths in children under 5 years of age approaching 1 million per year (1). Despite this mortality, S. pneumoniae is a component of the normal microflora of the human nasopharynx. It is estimated that at any given time, approximately 10 to 15% of adults and 25 to 40% of healthy children may be asymptomatically colonized with S. pneumoniae (2). Although only a small fraction of carriers progress to invasive or localized pneumococcal disease, the scale of the denominator results in massive global disease burden.S. pneumoniae is a diverse, genetically plastic species, and the 93 known capsular serotypes are superimposed on Ͼ5,000 sequence types (ST) recognizable by multilocus sequence type (MLST) analysis (3). It has a core genome of roughly 1,500 genes common to all strains, with the remaining 30% of the genome comprising accessory regions (AR) present in some but not all clonal lineages. Individual S. pneumoniae strains differ markedly in their capacity to ca...